Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Reid

Showing results (1331-1340 of 1,568) with videos related to

Pageof 157
Sort By:
Cell Metabolism|December 7, 2007
Respiratory uncoupling in skeletal muscle delays death and diminishes age-related diseaseAllison C Gates, Carlos Bernal-Mizrachi, Sharon L Chinault, et al.
The Journal of Clinical Endocrinology and Metabolism|January 18, 2007
Annual zoledronate increases bone density in highly active antiretroviral therapy-treated human immunodeficiency virus-infected men: a randomized controlled trialMark J Bolland, Andrew B Grey, Anne M Horne, et al.
Biomolecules|July 8, 2016
Turning on the Radio: Epigenetic Inhibitors as Potential Radiopriming AgentsBryan Oronsky, Jan Scicinski, Michelle M Kim, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|February 17, 2016
Continuous treatment with odanacatib for up to 8 years in postmenopausal women with low bone mineral density: a phase 2 studyR Rizzoli, C-L Benhamou, J Halse, et al.
Journal of Lower Genital Tract Disease|May 8, 2015
A prospective study of biopsy-confirmed cervical intraepithelial neoplasia grade 1: colposcopic, cytological, and virological risk factors for progressionM D Greenberg, R Reid, M Schiffman, et al.
Clinical Endocrinology|June 6, 2007
Bone mineral density remains stable in HAART-treated HIV-infected men over 2 yearsMark J Bolland, Andrew B Grey, Anne M Horne, et al.
The Medical Journal of Australia|August 4, 2010
Treatment for osteoporosis in Australian residential aged care facilities: consensus recommendations for fracture preventionGustavo Duque, Jacqueline J Close, Julien P de Jager, et al.
The American Journal of Medicine|October 6, 2000
Hydrochlorothiazide reduces loss of cortical bone in normal postmenopausal women: a randomized controlled trialI R Reid, R W Ames, B J Orr-Walker, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 17, 2008
Effects of intravenous zoledronate on bone turnover and BMD persist for at least 24 monthsMark J Bolland, Andrew B Grey, Anne M Horne, et al.
Molecular & Cellular Proteomics : MCP|October 17, 2015
An Integrated Multiomics Approach to Identify Candidate Antigens for Serodiagnosis of Human OnchocerciasisSamantha N McNulty, Bruce A Rosa, Peter U Fischer, et al.
Pageof 157

Showing results (1331-1340 of 1,568) with videos related to

Sort By:
Pageof 157
Cell Metabolism|December 7, 2007
Respiratory uncoupling in skeletal muscle delays death and diminishes age-related diseaseAllison C Gates, Carlos Bernal-Mizrachi, Sharon L Chinault, et al.
The Journal of Clinical Endocrinology and Metabolism|January 18, 2007
Annual zoledronate increases bone density in highly active antiretroviral therapy-treated human immunodeficiency virus-infected men: a randomized controlled trialMark J Bolland, Andrew B Grey, Anne M Horne, et al.
Biomolecules|July 8, 2016
Turning on the Radio: Epigenetic Inhibitors as Potential Radiopriming AgentsBryan Oronsky, Jan Scicinski, Michelle M Kim, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|February 17, 2016
Continuous treatment with odanacatib for up to 8 years in postmenopausal women with low bone mineral density: a phase 2 studyR Rizzoli, C-L Benhamou, J Halse, et al.
Journal of Lower Genital Tract Disease|May 8, 2015
A prospective study of biopsy-confirmed cervical intraepithelial neoplasia grade 1: colposcopic, cytological, and virological risk factors for progressionM D Greenberg, R Reid, M Schiffman, et al.
Clinical Endocrinology|June 6, 2007
Bone mineral density remains stable in HAART-treated HIV-infected men over 2 yearsMark J Bolland, Andrew B Grey, Anne M Horne, et al.
The Medical Journal of Australia|August 4, 2010
Treatment for osteoporosis in Australian residential aged care facilities: consensus recommendations for fracture preventionGustavo Duque, Jacqueline J Close, Julien P de Jager, et al.
The American Journal of Medicine|October 6, 2000
Hydrochlorothiazide reduces loss of cortical bone in normal postmenopausal women: a randomized controlled trialI R Reid, R W Ames, B J Orr-Walker, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 17, 2008
Effects of intravenous zoledronate on bone turnover and BMD persist for at least 24 monthsMark J Bolland, Andrew B Grey, Anne M Horne, et al.
Molecular & Cellular Proteomics : MCP|October 17, 2015
An Integrated Multiomics Approach to Identify Candidate Antigens for Serodiagnosis of Human OnchocerciasisSamantha N McNulty, Bruce A Rosa, Peter U Fischer, et al.
Pageof 157